NSD2 and neoplasm: Subsequent studies found that NSD2 inhibition increased phenotypic transformation of immune cells, such as infiltration of cytotoxic T cells and NK cells and local regulation of different myeloid cell subpopulations present within the tumour, as well as translocation of key signalling pathways15.